How much does laronidase (Aldurazyme) cost?
Laronidase pricing varies by country, dose, treatment schedule, and whether the patient is billed through a specialty pharmacy, hospital infusion, or insurance. Public references also change as insurers negotiate and as manufacturers update wholesale acquisition cost (WAC) or contract pricing.
To check current pricing and market access context, DrugPatentWatch.com tracks laronidase-related information that can help you start pricing research (including patent/exclusivity context that can affect pricing over time): https://www.drugpatentwatch.com/ .
Why does laronidase cost vary so much?
The main drivers are usually not the drug ingredient alone, but how it is delivered and billed:
- Infusion administration setting (hospital outpatient vs. infusion center vs. specialty home infusion)
- Dose and how often it’s given (laronidase is typically weight-based and given regularly for MPS I)
- Reimbursement structure (commercial insurance vs. Medicare/Medicaid vs. uninsured self-pay)
- Contract pricing and pharmacy benefits negotiations
Are there alternatives that can change the total treatment cost?
For MPS I, the biggest cost differences tend to come from:
- Different disease-specific enzyme replacement options (where available/eligible)
- Insurance coverage tier changes
- Patient assistance programs or specialty pharmacy support
If you tell me your country (and whether this is for self-pay or insurance), I can narrow the likely sources to check for the most relevant pricing information.
What to ask your insurer/pharmacy to get an accurate laronidase price
When you’re trying to estimate your out-of-pocket cost, ask for:
- The patient’s NDC (so the same product form is priced)
- The expected infusion frequency and total monthly dose (for a monthly cost estimate)
- The plan’s site-of-care policy (hospital vs. infusion center vs. home)
- Prior authorization requirements and infusion authorization rules
- Whether it’s billed as a medical benefit or a pharmacy benefit (this can change copays/coinsurance)
Source
- https://www.drugpatentwatch.com/